Investigating long-term complications in patients with deep venous thrombosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cohort study aims to analyze biomarkers related to inflammation, immunity, and aging in patients experiencing their first episode of lower extremity deep venous thrombosis (DVT), with a focus on those who have or have not been infected with SARS-CoV-2. The study will follow participants for two years to assess the development of long-term complications, particularly post-thrombotic syndrome (PTS). By comparing biomarker levels at diagnosis, the researchers hope to identify factors that contribute to the risk of developing PTS and other complications. The study will involve blood sampling and ultrasound examinations to gather necessary data.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years or above
* First time lower extremity DVT
* Hospitalized at the Emergency Department

Exclusion Criteria:

* Patients without a Danish social security number
* Terminal patients
* Patients who do not understand or speak Danish

Where it's running

• Copenhagen University Hospital Hvidovre
  Hvidovre, Copenhagen, Denmark Recruiting

Study contacts

• Principal investigator: Ove Andersen, M.D., Ph.D. — Department of Clinical Research
• Study coordinator: Izzet Altintas, M.D.
• Email: izzet.altintas@regionh.dk
• Phone: 004531252292

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Improving measures of nutrition, inflammation, kidney function, body composition, and hydration in older adults

  This project will test whether modern blood tests and body-measure techniques give more accurate estimates of nutrition and kidney health for hospitalized people aged 65 and older.

  Recruiting Hvidovre University Hospital · Copenhagen · NCT07501195

• Daily fisetin supplement to support healthy aging

  This will see if taking one 100 mg fisetin capsule daily for seven weeks lowers inflammation and supports overall health in people aged 50 and older.

  Recruiting Hvidovre University Hospital · Hvidovre · NCT07195318

• Daily probiotic supplement for healthy newborns

  We're testing whether giving a daily probiotic to healthy newborns from about two weeks to nine months helps their gut microbiome and overall health.

  Recruiting Hvidovre University Hospital · Hvidovre, Region Sjælland and 1 other locations · NCT07054216

• Social Prescribing in Vesterbro-Sydhavnen: linking patients to community support

  This project will try social prescribing with adults in Vesterbro-Sydhavnen who have complex health or social needs to see if connecting them to community services reduces loneliness and urgent healthcare use.

  Recruiting Hvidovre University Hospital · Copenhagen · NCT07029334

• Effects of bile acids on glucose metabolism after gastric bypass surgery

  This study is testing how bile acids affect blood sugar levels in people who have had gastric bypass surgery by giving some participants a medication and comparing their results to others.

  Recruiting Early Phase 1 Hvidovre University Hospital · Hvidovre · NCT06925997

• Progressive gait training for people after a first lower‑leg deep vein thrombosis

  This will test if adding progressive walking (gait) training to standard care improves quality of life for adults after a first lower‑extremity DVT.

  Recruiting Hvidovre University Hospital · Hvidovre, Capital Region · NCT06909240

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.